Alland Leila, director at Abeona Therapeutics Inc. ($ABEO), made one open market sale of common shares in the last year, totaling about $92,000. Her most recent ABEO insider sale occurred on February 2, 2026. This ranks her 9,707th among 11,678 insiders by sale value, well below the average of 8.6 million per person across about 6.4 transactions. She reported no open market purchases.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 2, 2026 | ABEONA THERAPEUTICS INC. | $ABEO | Alland Leila | Director | S | Common Stock | 18065 | $5.09 | 173,614.0000 | 65,780,650 | 9.42% | 0.03% |
| Jan. 26, 2026 | ABEONA THERAPEUTICS INC. | $ABEO | Alland Leila | Director | A | Common Stock | 37313 | $0.00 | 191,679.0000 | 65,780,650 | 24.17% | 0.06% |
| Jan. 31, 2025 | ABEONA THERAPEUTICS INC. | $ABEO | Alland Leila | Director | A | Common Stock | 36101 | $0.00 | 154,366.0000 | 41,048,206 | 30.53% | 0.09% |
| Aug. 26, 2024 | ABEONA THERAPEUTICS INC. | $ABEO | Alland Leila | Director | A | Common Stock | 11797 | $0.00 | 118,265.0000 | 21,380,476 | 11.08% | 0.06% |
| July 8, 2024 | ABEONA THERAPEUTICS INC. | $ABEO | Alland Leila | Director | A | Common Stock | 23611 | $0.00 | 106,468.0000 | 21,380,476 | 28.50% | 0.11% |
| May 16, 2024 | ABEONA THERAPEUTICS INC. | $ABEO | Alland Leila | Director | P | Common Stock | 11000 | $4.71 | 82,857.0000 | 21,380,476 | 15.31% | 0.05% |
| Sept. 15, 2023 | PMV Pharmaceuticals, Inc. | $PMVP | Alland Leila | Chief Medical Officer | S | Common Stock | 6291 | $6.62 | 45,909.0000 | 0 | 12.05% | 0.00% |
| May 12, 2023 | PMV Pharmaceuticals, Inc. | $PMVP | Alland Leila | Chief Medical Officer | A | Employee Stock Option (right to buy) | 100000 | $0.00 | 100,000.0000 | 0 | 9999.99% | 0.00% |